NCT06279676Recruiting
Improvement of Women's Health After Allogeneic Stem Cell Transplantation
Source: ClinicalTrials.gov · Last updated 18 Mar 2026
Brief summary (registry, in English)
The aim of this prospective research project is to better understand vulvovaginal cGVHD to improve care of allografted women. The expected outcomes include better knowledge of the incidence and manifestations of vulvovaginal cGVHD, risk factors, response to treatments and impact on sexual health of allotransplanted female patients. The knowledge acquired will allow transplant clinicians to make more precise recommendations for gynecological management of future allografted women.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 15 Dec 2023
- Start date
- 27 Aug 2024
- Primary completion date
- Jul 2028
- Lead sponsor
- Ciusss de L'Est de l'Île de Montréal
- NCT number
- NCT06279676
What you commit to
- Study type: Observational
- Planned participants: 100
- From 27 Aug 2024 to the primary completion date, Jul 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Those who receive an autologous transplant.
Other
- Those who receive a second HSCT allograft.
- Inability to give informed consent.
- Unable to communicate in French or English.
- Any other reason which, according to the investigators, makes it preferable for a patient not to participate.
Who the study is looking for
- All women aged 18 and over who will receive a first allogeneic HSCT (bone marrow, peripheral blood stem cells from a related, unrelated (including cord blood) or haploidentical donor) at the CIUSSS-EMTL. Recruitment will begin when the project receives ethical approval. Recruitment period will be of 2 to 3 years.
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CIUSSS de l Est de l Ile de Montreal - Hopital Maisonneuve Rosemont Coordinator of this site? Confirm its status | Montreal | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.